Prudential Financial Inc Atea Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$2.8 - $3.35 $10,920 - $13,065
-3,900 Reduced 3.42%
110,105 $335,000
Q3 2023

Nov 13, 2023
SELL
$3.0 - $3.79 $305,700 - $386,201
-101,900 Reduced 47.2%
114,005 $342,000
Q2 2023

Aug 11, 2023
SELL
$3.21 - $5.06 $75,435 - $118,909
-23,500 Reduced 9.82%
215,905 $807,000
Q1 2023

May 12, 2023
SELL
$3.0 - $4.97 $108,900 - $180,411
-36,300 Reduced 13.17%
239,405 $802,000
Q4 2022

Feb 14, 2023
SELL
$4.35 - $6.17 $82,345 - $116,798
-18,930 Reduced 6.42%
275,705 $0
Q3 2022

Nov 04, 2022
SELL
$5.49 - $8.79 $465,003 - $744,512
-84,700 Reduced 22.33%
294,635 $1.68 Million
Q2 2022

Aug 15, 2022
SELL
$5.33 - $8.18 $361,267 - $554,440
-67,780 Reduced 15.16%
379,335 $2.69 Million
Q1 2022

May 13, 2022
BUY
$5.5 - $9.19 $355,300 - $593,674
64,600 Added 16.89%
447,115 $3.23 Million
Q4 2021

Feb 14, 2022
BUY
$7.67 - $44.59 $2.93 Million - $17.1 Million
382,515 New
382,515 $3.42 Million
Q3 2021

Nov 15, 2021
SELL
$21.33 - $35.06 $1.43 Million - $2.34 Million
-66,875 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$19.22 - $59.08 $68,423 - $210,324
-3,560 Reduced 5.05%
66,875 $1.44 Million
Q1 2021

May 12, 2021
BUY
$41.42 - $88.44 $2.92 Million - $6.23 Million
70,435 New
70,435 $4.35 Million

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $266M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email